Bay Street News, March, 2020

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company […]

DSG3-CAART IND clearance received in October 2019 and Orphan Drug Designation granted by the FDA for the treatment of pemphigus […]

LEXINGTON, Mass. and AMSTERDAM, March 30, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]

GAITHERSBURG, Md., March 30, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]

RESEARCH TRIANGLE PARK, N.C., March 30, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that the European Medicines […]

SUGAR LAND, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (Nasdaq: AAOI), a leading provider of fiber-optic access […]

Ongoing strong financial position with CHF 288.6 million in cash, ensuring the Company is fully financed through Q1 2024, excluding […]

ROAD TOWN, British Virgin Islands and VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) […]

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (Cardinal or Company) (ASX:CDV, TSX:CDV), an advanced West African gold […]

MISSISSAUGA, Ontario, March 30, 2020 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, Microbix®) announces the creation, verification, and imminent […]